Literature DB >> 12470574

Maturational and developmental competence of immature oocytes retrieved from bovine ovaries at different phases of folliculogenesis.

Ri-Cheng Chian1, Jin-Tae Chung, Bruce R Downey, Seang Lin Tan.   

Abstract

Immature oocytes recovered from bovine ovaries were studied to determine if their maturational and developmental competence is affected by phase of folliculogenesis. Ovaries (a total of 39 pairs) were collected from a local abattoir. Following examination, each pair of ovaries was assigned to one of three groups, according to follicle size and with or without a corpus luteum: (i) early phase (n = 13 pairs): all follicles were <or=8 mm in diameter; (ii) late phase (n = 13 pairs): the largest follicle was >or=15 mm in diameter; (iii) luteal phase (n = 13 pairs): all follicles were <or=8 mm in diameter and there was a corpus luteum on one of the ovaries. All follicles were aspirated and cumulus-oocytes complexes (COC) were cultured in 1.0 ml maturation medium, TC-199 medium supplemented with 10% fetal bovine serum (FBS), 0.2 mmol pyruvate, and 75 mIU/ml FSH and LH (Humegon) at 38.5 degrees C in a humidified atmosphere of 5% CO(2) and 95% air for 24 h. Following maturation in vitro, the oocytes were inseminated with frozen-thawed semen and cultured for further development in vitro. The mean number of oocytes retrieved from early phase ovaries was 32 +/- 8.1 which was significantly higher (P < 0.05) than other phases (n = 20.1 +/- 5.4 and 22.7 +/- 6.9). The numbers of degenerated oocytes from early, late and luteal phase ovaries were not different (n = 1.6 +/- 0.7, 1.8 +/- 0.5 and 1.5 +/- 0.5, respectively). The rates of oocyte maturation (84.4%, 89.2% and 83.6%) and fertilization (53.5%, 53.3% and 51.3%) were not significantly different across the three groups. In addition, there were no significant differences in the rates of cleavage (77.9%, 79.9% and 73.9%) and blastocyst formation (27.4%, 33.0% and 30.4%) in the three groups. These results indicate that the maturational and developmental competence of immature oocytes is not affected by the phase of folliculogenesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12470574     DOI: 10.1016/s1472-6483(10)61929-3

Source DB:  PubMed          Journal:  Reprod Biomed Online        ISSN: 1472-6483            Impact factor:   3.828


  13 in total

1.  Thirteen years' experience in fertility preservation for cancer patients after in vitro fertilization and in vitro maturation treatments.

Authors:  Helene Creux; Patricia Monnier; Weon-Young Son; William Buckett
Journal:  J Assist Reprod Genet       Date:  2018-03-03       Impact factor: 3.412

2.  Natural cycle IVF/IVM may be more desirable for poor responder patients after failure of stimulated cycles.

Authors:  Jianhua Li; Ye Xu; Guoping Zhou; Junhong Guo; Nan Xin
Journal:  J Assist Reprod Genet       Date:  2011-06-22       Impact factor: 3.412

3.  Fertilization, embryo development, and clinical outcome of immature oocytes obtained from natural cycle in vitro fertilization.

Authors:  Weon-Young Son; Jin-Tae Chung; Mausumi Das; William Buckett; Ezgi Demirtas; Hananel Holzer
Journal:  J Assist Reprod Genet       Date:  2012-11-21       Impact factor: 3.412

4.  Denudation and sperm injection interval timing: impact on outcome of intracytoplasmic sperm injection.

Authors:  Fatma Aletebi
Journal:  Int J Womens Health       Date:  2011-03-15

5.  Clinical benefit of metaphase I oocytes.

Authors:  Leen Vanhoutte; Petra De Sutter; Josiane Van der Elst; Marc Dhont
Journal:  Reprod Biol Endocrinol       Date:  2005-12-15       Impact factor: 5.211

6.  The role of menstrual cycle phase and AMH levels in breast cancer patients whose ovarian tissue was cryopreserved for oncofertility treatment.

Authors:  Seido Takae; Yodo Sugishita; Nobuhito Yoshioka; Mariko Hoshina; Yuki Horage; Yorino Sato; Chie Nishijima; Kazuhiro Kawamura; Nao Suzuki
Journal:  J Assist Reprod Genet       Date:  2014-12-03       Impact factor: 3.412

Review 7.  In vitro maturation: Clinical applications.

Authors:  Kyung Sil Lim; Soo Jin Chae; Chang Woo Choo; Yeon Hee Ku; Hye Jun Lee; Chang Young Hur; Jin Ho Lim; Won Don Lee
Journal:  Clin Exp Reprod Med       Date:  2013-12-31

8.  Luteal-phase protocol in poor ovarian response: a comparative study with an antagonist protocol.

Authors:  Yan Wu; Fu-Chun Zhao; Yong Sun; Pei-Shu Liu
Journal:  J Int Med Res       Date:  2017-01-16       Impact factor: 1.671

9.  FSH receptor binding inhibitor impacts K-Ras and c-Myc of ovarian cancer and signal pathway.

Authors:  Suocheng Wei; Xiaoyun Shen; Luju Lai; Haoqin Liang; Yingying Deng; Zhuandi Gong; Tuanjie Che
Journal:  Oncotarget       Date:  2018-04-27

10.  Comparison of GnRH agonist and hCG for priming in vitro maturation cycles in cancer patients undergoing urgent fertility preservation.

Authors:  Hady El Hachem; Charlotte Sonigo; Julie Benard; Marion Presse; Christophe Sifer; Nathalie Sermondade; Michael Grynberg
Journal:  PLoS One       Date:  2018-12-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.